• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Treatment of Liver Tumors Using a Novel Bipolar Radiofrequency Ablation Device

Treatment of Liver Tumors Using a Novel Bipolar Radiofrequency Ablation Device

Background: Laparoscopic ablation and resection of liver tumors is rapidly gaining momentum. Well over a decade ago, monopolar RFA devices were introduced and replaced cryoablation as the preferred modality for ablating liver tumors. Bipolar RFA technology which requires placement of two probes works fast and can be used for two distinct purposes. We describe our early experience using laparoscopic bipolar RFA technology for (1) tumor ablation, (2) parenchymal precoagulation prior to transection, and in selected cases both applications were used.
Methods: We reviewed our prospectively maintained database of patients with liver tumors treated by laparoscopic approach utilizing the bipolar RFA device. We identified 14 patients that underwent laparoscopic RFA of liver tumors, resection or both procedures. RFA alone was used in patients with contraindications to resection or as bridge therapy toward transplantation. We analyzed the indications and operative approach for these operations. Some procedures were done with the patient in the left lateral decubitus and others in the supine position. The liver is fully mobilized off of the retroperitoneum and diaphragm to fully access the tumor baring segments. RFA was done using the InCircle (RFA-medical) bipolar probes in all cases. During laparoscopic resections, the parenchyma was precoagulated using the Monarch probes (RFA-medical) which have linearly oriented deployable tines. In most cases parenchymal division was done using the Gyrus cutting bipolar forceps (Olympus) depending on nature of the liver parenchyma.
Results: Of the 14 study patients, 8 underwent totally laparoscopic liver resections and 6 underwent laparoscopic RFA alone. The median age was 64.4 (range 44-82). The indications for surgery included primary liver tumors in 12 cases (hepatocellular carcinoma = 10; cholangiocarcinoma = 1 ; hepatic adenoma = 1) and metastatic tumors in 2 cases (breast and colorectal). All hepatomas arose in the context of chronic HCV and thus some degree of fibrosis/cirrhosis. Among those patients treated by RFA alone, the average tumor size was 4.0 cm (range 2.3-6). Two patients underwent concomitant procedures (cholecystectomy in 1; placement of gold fiducials in 1). Totally laparoscopic resections were completed in 8 patients. None required conversion to open. The average tumor size was 4.2(range 2.9-5). Of these, 6 patients underwent anatomic resection (2 formal right hepatectomies, 2 posterior sectorectomies, 2 monosegmentectomies: seg 5, seg 2). Two other patients underwent non-anatomic resections both in segment 6.
Conclusion: Laparoscopic Bipolar RFA technology can be used as an adjunct to totally laparoscopic hepatic resections or tumor ablation alone. While multiple energy devices exist for tumor ablation or parenchymal precoagulation, only the Bipolar RFA device can be used efficiently for both purposes. Bipolar RFA is an excellent alternative to monopolar RFA technology and may be next in line as the preferred energy for treating liver tumors.


Session: Poster

Program Number: P393

View Poster

534

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals